Výsledky vyhľadávania - "Glaucoma economics"
-
1
Autori:
Zdroj: Olsen, J, Berdeaux, G & Skov, J 2013, ' Glaucoma costs in Denmark in treatment naive patients ', Acta Ophthalmologica, vol. 91, no. 1, pp. 25-31 . https://doi.org/10.1111/j.1755-3768.2011.02212.x
Predmety: Antihypertensive Agents/economics, Male, Health Care Costs/statistics & numerical data, Denmark, Incidence, costs, Glaucoma, economics, Health Care Costs, Filtering Surgery/economics, Denmark/epidemiology, 3. Good health, 03 medical and health sciences, glaucoma, 0302 clinical medicine, Filtering Surgery, ocular hypertension, Humans, Female, Registries, Health Expenditures, Antihypertensive Agents, budget, Glaucoma/economics, Aged
Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1755-3768.2011.02212.x
https://pubmed.ncbi.nlm.nih.gov/21834919
http://europepmc.org/abstract/MED/21834919
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2011.02212.x/abstract
https://www.ncbi.nlm.nih.gov/pubmed/21834919
https://portal.findresearcher.sdu.dk/da/publications/glaucoma -costs-in-denmark-in-treatment-naive-patients
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1755-3768.2011.02212.x
https://portal.findresearcher.sdu.dk/da/publications/91864db8-5caf-4867-a23a-8f215a84b683
https://doi.org/10.1111/j.1755-3768.2011.02212.x
https://portal.findresearcher.sdu.dk/da/publications/91864db8-5caf-4867-a23a-8f215a84b683 -
2
Autori:
Zdroj: Revista Brasileira de Oftalmologia, Vol 75, Iss 4, Pp 336-341
Revista Brasileira de Oftalmologia v.75 n.4 2016
Revista Brasileira de Oftalmologia
Sociedade Brasileira de Oftalmologia (SBO)
instacron:SBO
Revista Brasileira de Oftalmologia, Volume: 75, Issue: 4, Pages: 336-341, Published: AUG 2016Predmety: Glauco/therapy, Cost-benefit analysis, Saúde Pública, Economia da Saúde, RE1-994, Análise de custo-benefício, Ophthalmology, Glaucoma/diagnóstico, Glaucoma/terapia, Glaucoma/economia, Public Health, Health economics, Glaucoma/diagnosis, Glaucoma/economics
Popis súboru: text/html
-
3
Autori: a ďalší
Zdroj: GMS Health Technology Assessment; VOL: 7; DOC05 /20110915/
Predmety: TECHNOLOGY ASSESSMENT, BIOMEDICAL, CLINICAL TRIALS AS TOPIC, CONTROLLED CLINICAL TRIALS AS TOPIC, COST-BENEFIT ANALYSIS, COSTS AND COST ANALYSIS, DECISION MAKING, ECONOMICS, MEDICAL, EFFICIENCY, ENDOMETRIAL NEOPLASMS, ENDOMETRIAL NEOPLASMS/ECONOMICS, EVALUATION STUDIES AS TOPIC, EVIDENCE-BASED MEDICINE, GLAUCOMA, GLAUCOMA/ECONOMICS, HEALTH CARE COSTS, HEALTH CARE COSTS/*ETHICS, HEALTH CARE COSTS/*STANDARDS, HUMANS, INSURANCE BENEFITS, INSURANCE, HEALTH, REIMBURSEMENT, INTERVIEWS AS TOPIC, MASS SCREENING, META-ANALYSIS AS TOPIC, PEER REVIEW, PHYSICIAN-PATIENT RELATIONS/*ETHICS, RANDOMIZED CONTROLLED TRIALS AS TOPIC
Relation: http://dx.doi.org/10.3205/hta000096; http://nbn-resolving.de/urn:nbn:de:0183-hta0000960; http://www.egms.de/en/journals/hta/2011-7/hta000096.shtml
-
4
Autori: a ďalší
Predmety: Glaucoma/economia, Glaucoma/quimioterapia, Pressão intraocular/economia, Pressão intraocular/quimioterapia, Anti-hipertensivos/economia, Antihipertensivos/administração & dosagem, Timolol/administração & dosagem, Timolol/economia, Prostaglandinas F sintéticas/administração & dosagem, Prostaglandinas F sintéticas/economia, Combinação de medicamentos, Análise custo-efetividade, Glaucoma/economics, Glaucoma/drug therapy, Intraocular pressure/economics, Intraocular pressure/drug therapy, Antihypertensive agents/ administration & dosage Antihypertensive agents/economics, Timolol/administration & dosage, Timolol/economics, Prostaglandins F, Synthetic/administration & dosage, synthetic/economics, Drug combinations, Cost-effectiveness analysis
Popis súboru: application/pdf
Relation: Revista Brasileira de Oftalmologia; https://repositorio.ufjf.br/jspui/handle/ufjf/8498
-
5
Additional Titles: Individuelle Gesundheitsleistungen
Autori: a ďalší
Zdroj: GMS Health Technology Assessment; VOL: 7; DOC05 /20110915/
Témy: TECHNOLOGY ASSESSMENT, BIOMEDICAL, CLINICAL TRIALS AS TOPIC, CONTROLLED CLINICAL TRIALS AS TOPIC, COST-BENEFIT ANALYSIS, COSTS AND COST ANALYSIS, DECISION MAKING, ECONOMICS, ECONOMICS, MEDICAL, EFFICIENCY, ENDOMETRIAL NEOPLASMS, ENDOMETRIAL NEOPLASMS/ECONOMICS, EVALUATION STUDIES AS TOPIC, EVIDENCE-BASED MEDICINE, GLAUCOMA, GLAUCOMA/ECONOMICS, HEALTH CARE COSTS, HEALTH CARE COSTS/*ETHICS, HEALTH CARE COSTS/*STANDARDS, HUMANS, INSURANCE BENEFITS, INSURANCE, HEALTH, REIMBURSEMENT, INTERVIEWS AS TOPIC, MASS SCREENING, META-ANALYSIS AS TOPIC, PEER REVIEW, PHYSICIAN-PATIENT RELATIONS/*ETHICS, RANDOMIZED CONTROLLED TRIALS AS TOPIC, REVIEW LITERATURE AS TOPIC, RISK ASSESSMENT, SOCIOECONOMIC FACTORS, TECHNOLOGY, TECHNOLOGY, MEDICAL, THERAPY, TECHNIKFOLGEN-ABSCHÄTZUNG, BIOMEDIZINISCHE, KLINISCHE STUDIEN, KONTROLLIERTE KLINISCHE STUDIEN, KOSTEN-NUTZEN-ANALYSE, KOSTEN UND KOSTENANALYSE, ENTSCHEIDUNGSFINDUNG, ÖKONOMIE, ÖKONOMIE, ÄRZTLICHE, EFFIZIENZ, ENDOMETRIUMTUMOREN, EVALUATIONSSTUDIEN, GUTACHTENBASIERTE MEDIZIN, GLAUKOM, MENSCH, VERSICHERUNGSLEISTUNGEN, INTERVIEWS, REIHENUNTERSUCHUNG, METAANALYSE, RANDOMISIERTE KONTROLLIERTE STUDIEN, ÜBERSICHTSLITERATUR, RISIKOABSCHÄTZUNG, SOZIALÖKONOMISCHE FAKTOREN, TECHNOLOGIE, TECHNOLOGIE, MEDIZINISCHE, accident, additional benefit, add-on benefit, appropriateness, benefit package, biomedical technology assessment, care, catalogue of benefits, catalogue of services, clinical freedom, clinical trials as topic, commercialisation, commercialization, controlled clinical trials as topic, co-payment, cost analysis, cost control, cost effectiveness, cost reduction, cost repayment, cost-benefit analyses, cost-cutting, cost-effectiveness, costs, costs and cost analysis, decision making, demand, diagnosis, Doctor's duty to give patients information, EBM, economic aspect, economics, economics, medical, effectiveness, efficacy, efficiency, endometrial neoplasms, endometrial neoplasms/economics, ethics, evaluation studies as topic, evidence based medicine, Federal Joint Commitee, fee schedule, freedom of therapy, glaucoma, glaucoma/economics, health care costs, health care costs/*ethics, health care costs/*standards, health economic studies, health economics, health insurance fund, health technology assessment, HTA, HTA report, HTA-report, humans, individual health services, insurance benefits, insurance, health, reimbursement, interview, interviews as topic, juricical, mass screening, medical assessment, medical costs, medical evaluation, meta analysis as topic, methods, obligation to pay, obligation to render services, obligation to supply services, offer, Peer review, physician-patient relations/*ethics, poll, prevention, preventive benefits, preventive services, private health insurance, private service, random, random allocation, randomisation, randomization, randomized controlled trials as topic, range of benefits, reimbursement of costs, report, return of costs, review, review literature, review literature as topic, risk assessment, screening, screening for glaucoma, self retention, sensitivity, social economic factors, socioeconomic factors, socioeconomics, specifity, statutory health insurance, supplementary benefit, survey, systematic review, technical report, technology, technology assessment, technology assessment, biomedical, technology evaluation, technology, medical, therapy, treatment, vaginal ultrasound, VUS, Angebot, Angemessenheit, ärztliche Aufklärungspflicht, Arzt-Patient-Beziehungen/*Ethik, Behandlung, Beurteilung, EbM, Effektivität, Effizienz, Eigenleistung, Endometriumtumoren, Endometriumtumoren/Ökonomie, Entscheidungsfindung, Ethik, evidenzbasierte Medizin, G-BA, Gebührenordnung, Gemeinsamer Bundesausschuss, Gesetzliche Krankenversicherung, Gesundheitsfinanzierung, Gesundheitsökonomie, gesundheitsökonomische Studien, GKV, Glaukom, Glaukom/Ökonomie, Glaukomscreening, GOÄ, gutachtenbasierte Medizin, Health technology assessment, HTA Bericht, HTA-Bericht, IGeL, Individuelle Gesundheitsleistung, Informationspflicht, Interviews, Kommerzialisierung, Kosten, Kosten Effektivität, Kosten und Kostenanalyse, Kostenanalyse, Kosteneffektivität, Kosten-Effektivität, Kostenerstattung, Kostenkontrolle, Kostenminimierung, Kosten-Nutzen-Analyse, Kostenreduktion, Kostensenkung, Krankenkasse, Krankheitskosten, medizinische Beurteilung, medizinische Bewertung, medizinische Technologie, medizinische Versorgungskosten, medizinische Versorgungskosten/*Ethik, medizinische Versorgungskosten/*Standard, Mensch, Methoden, Methodik, Nachfrage, Ökonomie, Ökonomie, ärztliche, ökonomischer Aspekt, Peer Review, PKV, Prävention, Private Krankenversicherung, Privatleistung, Reihenuntersuchung, Risikoabschätzung, Screening, Selbstbeteiligung, Selbstzahlerleistung, Sensitivität, sozialökonomische Faktoren, Sozioökonomie, sozioökonomische Faktoren, sozio-ökonomische Faktoren, Spezifität, systematische Übersicht, Technikfolgen-Abschätzung, biomedizinische, Technologie, Technologie, medizinische, Technologiebeurteilung, Technologiebewertung, Therapie, Therapiefreiheit, Übersichtsarbeit, Übersichtsliteratur, Vaginaler Ultraschall, Versicherung, Kranken-, Leistung, Versicherungsleistungen, Versorgungsauftrag, Vorsorge, Wahlsystem, Wirksamkeit, Wunschsystem, Zusatzleistung, ddc: 610, article
Full Text Finder
Nájsť tento článok vo Web of Science